Heron Therapeutics, Inc. (HRTX): Tang Capital Partners Raises Stake to 17%

Page 4 of 6 – SEC Filing

CUSIP NO. 427746102
13D/A
    Page 4 of 8
1.
Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
Kevin C. Tang
2.
Check the Appropriate Box if a Member of a Group
(a) ¨
(b) ý
3.
SEC Use Only
4.
Source of Funds
PF, WC, OO
5.
Check If Disclosure of Legal Proceeding Is Required Pursuant to Items 2(d) or 2(e)
        ¨
6.
Citizenship or Place of Organization
United States
Number of
Shares
Beneficially
Owned by
Each Reporting
Person With
7.
Sole Voting Power
410,213
8.
Shared Voting Power
6,117,530
9.
Sole Dispositive Power
410,213
10.
Shared Dispositive Power
6,117,530
11.
Aggregate Amount Beneficially Owned by Each Reporting Person
6,527,743
12.
Check if the Aggregate Amount in Row (11) Excludes Certain Shares          ¨
13.
Percent of Class Represented by Amount in Row (11)
                 17.4%
14
Type of Reporting Person
IN

Follow Heron Therapeutics Inc. (NASDAQ:HRTX)